A phase 3 randomized placebo-controlled trial to assess the efficacy and safety of ipragliflozin as an add-on therapy to metformin in Russian patients with inadequately controlled type 2 diabetes mellitus
published in: Diabetes Research and Clinical Practice
date of publication: 2018-11-01
language: English
main subject: type 2 diabetes, placebo, phase III clinical trial, metformin, placebo-controlled trial
Cites articles
There is nothing here
Article - wd:Q58583217